Ovid Therapeutics Inc.
Status: Publicly traded
Direct answer
Ovid Therapeutics Inc. is publicly traded on NASDAQ under the ticker OVID.
Ovid Therapeutics Inc. is a biopharmaceutical firm dedicated to creating significant treatments for individuals and families impacted by neurological disorders across the United States. The company's robust pipeline features several key therapeutic candidates: OV101, a drug candidate currently undergoing Phase 2A clinical trials for Fragile X syndrome; OV329, an inhibitor targeting GABA aminotransferase, aimed at...
Can you invest in Ovid Therapeutics Inc.?
Yes. Ovid Therapeutics Inc. trades publicly on NASDAQ as OVID.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Ovid Therapeutics Inc.
Detailed equity research is provided by MarketSnap.